GEP20012487B - Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose - Google Patents

Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose

Info

Publication number
GEP20012487B
GEP20012487B GEAP19984490A GEAP1998004490A GEP20012487B GE P20012487 B GEP20012487 B GE P20012487B GE AP19984490 A GEAP19984490 A GE AP19984490A GE AP1998004490 A GEAP1998004490 A GE AP1998004490A GE P20012487 B GEP20012487 B GE P20012487B
Authority
GE
Georgia
Prior art keywords
carbarnoyl
dibenz
azepin
analogues
derivatives
Prior art date
Application number
GEAP19984490A
Inventor
Merab Lomia
Original Assignee
Merab Lomia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merab Lomia filed Critical Merab Lomia
Priority to GEAP19984490A priority Critical patent/GEP20012487B/en
Publication of GEP20012487B publication Critical patent/GEP20012487B/en

Links

Abstract

1. Technical Result Increase in efficiency of treatment, reduction of side-effects, providing the stable remission and cure. 2. Essence A chemical agent 5-carbarnoyl-5H-dibenz (b,f) azepin, its derivatives and analogues are used for treating bronchial asthma, bronchospastic syndrome and diseases with such a syndrome. 3. Field of Application Medicine, therapy.
GEAP19984490A 1998-09-16 1998-09-16 Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose GEP20012487B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP19984490A GEP20012487B (en) 1998-09-16 1998-09-16 Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP19984490A GEP20012487B (en) 1998-09-16 1998-09-16 Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose

Publications (1)

Publication Number Publication Date
GEP20012487B true GEP20012487B (en) 2001-07-25

Family

ID=82787040

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19984490A GEP20012487B (en) 1998-09-16 1998-09-16 Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose

Country Status (1)

Country Link
GE (1) GEP20012487B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9879026B2 (en) 2014-09-12 2018-01-30 Boehringer Ingelheim International Gmbh Substituted spirocycles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9879026B2 (en) 2014-09-12 2018-01-30 Boehringer Ingelheim International Gmbh Substituted spirocycles

Similar Documents

Publication Publication Date Title
UA32429C2 (en) Agent for treatment of patient with enuresis
MXPA01004648A (en) Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody.
GEP20022656B (en) 2-(Purin-9-YL)-Tetrahydrofuran-3,4-Diol Derivatives
IL144559A0 (en) Antibodies for cancer therapy and diagnosis
NO20002409L (en) Procedures for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
GR3035593T3 (en) Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases
ES2149264T3 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF MELANOMAS.
CA2189916A1 (en) A new regime for paclitaxel in kaposi's sarcoma patients
WO1996003997A3 (en) Treatment of cancer using hsv mutant
ES2167401T3 (en) USE OF ASCORBIL-GAMMA-LINOLENATE OR ASCORBIL-DIHOMO-GAMMA-LINOLENATE FOR THE TREATMENT OF ASTHMA, CANCER, CARDIOVASCULAR DISEASES AND ANTI-INFLAMMATORIES.
AU6857887A (en) Therapeutic agent
BR9814419A (en) "combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of proliferative diseases"
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
DE69633396D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ACTIVIN STIMULATOR
GEP20012487B (en) Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose
ES8704962A1 (en) 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans.
BR0214564A (en) Cancer Treatment Processes Using a Fpt Inhibitor and Antineoplastic Agents
EP0378146A3 (en) Polyamine derivatives as antineoplastic agents
GEP20022612B (en) Principally New Indication of Anticonvulsants Use
NO971043L (en) Use of IL-4 for potentiation of chemotherapeutic agents
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
TR200000728T2 (en) The use of IFN-alpha and amantadine in the treatment of chronic hepatitis C.
UA6738A (en) Method for treating patients with bronchoobstructive syndrome in bronchial asthma and chronic obstructive bronchitis
陈荣钟 TREATMENT OF APOPLECTIC HEMIPLEGIA BY DIGITAL ACUPOINT PRESSURE-A Report of 42 Cases